An enzyme-replacement drip for ASMD (Niemann-Pick type B)
Olipudase alfa
An enzyme-replacement drip used to treat acid sphingomyelinase deficiency (ASMD), a rare inherited condition that affects the spleen, liver, lungs and blood.
What is Olipudase alfa?
Olipudase alfa is a specialist enzyme-replacement medicine used to treat acid sphingomyelinase deficiency (ASMD), a rare inherited condition also known as Niemann-Pick disease type B, in which a missing enzyme lets fatty material build up in organs such as the spleen, liver and lungs. It works by replacing the missing enzyme so the body can break down that build-up. It is given as a drip into a vein, with the amount built up gradually at the start. Infusion-associated reactions and temporary rises in liver tests are the main concerns, so it is given under specialist care.
Education and reference only. This is a plain-language guide to Olipudase alfa — it deliberately contains no doses. Doses depend on the person, the brand and the reason for treatment, and belong with your prescriber. Always check the BNF, the product labelling (SmPC) and follow medical advice.
What it is
Olipudase alfa is an enzyme-replacement therapy for acid sphingomyelinase deficiency (ASMD), also called Niemann-Pick disease type B, a rare inherited condition in which a lack of the enzyme acid sphingomyelinase lets a fatty material build up in cells, enlarging the spleen and liver and affecting the lungs and blood. Olipudase alfa is a manufactured copy of the missing enzyme, given as a drip (infusion) into a vein. Treatment is built up gradually at the start, and it is begun and supervised by a specialist team as a long-term treatment.
How it works
In ASMD, the missing enzyme means a fatty substance called sphingomyelin cannot be broken down, so it accumulates in cells in the spleen, liver, lungs and elsewhere, causing organ enlargement and other problems. Olipudase alfa supplies that enzyme, helping cells clear the trapped material and reducing the build-up that causes harm. As the build-up breaks down, some of the by-products can briefly stress the liver, which is one reason treatment is built up gradually at the start. Because the enzyme only works while it is present, it is given as regular infusions over the long term.
Company & origin
Originated / developed by: Specialist manufacturer.
A specialist enzyme-replacement medicine used in the UK to treat acid sphingomyelinase deficiency (ASMD), also known as Niemann-Pick disease type B.
Practical use
How to take Olipudase alfa
General, dose-free guidance — always follow your prescriber's and the leaflet's specific instructions.
- Have it as a drip into a vein, on a regular schedule, in a setting where reactions can be managed.
- Understand that treatment is built up gradually at the start, so it is not given at full strength straight away.
- Attend the blood tests your team arranges, as liver tests can rise temporarily during the build-up period.
- Watch for reactions during or soon after the drip, such as fever, headache, nausea, rash or feeling faint, and report them.
- Do not skip or stop treatment without specialist advice, as the benefits depend on keeping it going.
Weighing it up
Advantages & disadvantages of Olipudase alfa
Advantages
- Replaces the missing enzyme in ASMD, helping clear the fatty build-up that enlarges organs.
- Can reduce spleen and liver enlargement and support lung function over time.
- Offers a targeted treatment for a condition with otherwise limited options.
Disadvantages
- Given as a drip into a vein on a regular, long-term schedule, built up gradually at the start.
- Can cause infusion-associated reactions, including serious allergic reactions.
- Liver blood tests can rise temporarily, especially early in treatment, needing monitoring.
Practical use
Good to know
A particular feature of olipudase alfa is that treatment is built up step by step at the beginning rather than starting at full strength, because clearing the stored fatty material too quickly can briefly stress the liver and the body. Liver blood tests can rise temporarily during this build-up period, so the team checks them and may adjust the schedule. It is given as a drip into a vein, regularly and for the long term, in a setting where reactions can be managed. Infusion-associated reactions are a key concern, ranging from mild effects such as fever, headache or nausea during the drip to serious allergic and anaphylactoid reactions. It should not be stopped without specialist advice, and the team monitors organ size, lung function, blood counts and liver tests over time.
Who should not take it / use with caution
- People who have had a serious allergic reaction to olipudase alfa should not use it.
- It is used with care, and with close monitoring, in people who have had reactions to enzyme-replacement treatment before.
- It should only be used under specialist supervision where infusion reactions and liver changes can be managed.
Monitoring
- Liver blood tests, especially during the early build-up period, as these can rise temporarily.
- Reviewing spleen and liver size, lung function and blood counts over time.
- Watching closely for infusion-associated and allergic-type reactions during and after each drip.
Side effects
- Reactions during or soon after the drip, such as fever, headache, nausea, rash or feeling unwell.
- Temporary rises in liver blood tests, especially during the early build-up period.
- Aches, tiredness or, sometimes, changes in blood counts.
- Rarely, serious allergic or anaphylactoid reactions, which need urgent treatment.
Key interactions
- There are few well-established routine medicine interactions, but tell your team about everything you take.
- Medicines used to manage infusion reactions, such as antihistamines, may be given around the drip.
- Tell your team about any liver problems or previous reactions to enzyme-replacement treatment.
Available as: A powder made up into a solution given as a drip (infusion) into a vein.
Answers
Olipudase alfa: frequently asked questions
What is olipudase alfa used for?
It is used to treat acid sphingomyelinase deficiency (ASMD), also called Niemann-Pick disease type B, by replacing the missing enzyme so the body can break down fatty material that would otherwise build up in organs.
Why is treatment built up gradually?
Clearing the stored fatty material too quickly can briefly stress the liver and the body, so treatment is built up step by step at the start, with liver tests checked along the way.
How is it given?
It is given as a drip (infusion) into a vein on a regular schedule, in a setting where any reactions can be managed by the specialist team.
Why do my liver tests change?
Liver blood tests can rise temporarily, especially during the early build-up period, as the build-up breaks down; the team monitors them and may adjust the schedule.
Can it be stopped once my organs improve?
No. It is a long-term treatment whose benefits depend on continuing it, so only change or stop it on specialist advice.
Authoritative sources
- BNF
- NICE CKS
Building a medicines information resource?
We create evidence-led, dose-free drug and formulary references for teams.